Stock Market News | NASDAQ, NYSE, and AMEX Stock Market News, Market News Categories, Market Indicators

SIELUX Introduces the New X Series Handheld Laser Welding Machine, Engineered for Greater Efficiency in Real-World Applications

Today 21:09 EDT

Via Press Release Distribution Service

Palantir Technologies Announces October Seoul Pop-Up with Korea-First Exclusive Merchandise Release

Today 21:00 EDT

From Palantir Technologies Inc.

InnoCare Announces Approval of Clinical Trial of Bispecific Antibody ICP-B161 Targeting TL1A and IL-23p19 in China

Tickers PLTR

LCM Company Shares Five Tips for Upholstery Cleaning in Charlotte, NC

Today 13:47 EDT

Via PRLog

Today 20:30 EDT

From InnoCare Pharma

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY

CAPHRA: Asia-Pacific Cannot Afford to Ignore Lessons on Reducing Smoking

Today 20:04 EDT

Via PRLog

Topics Death

Exposures Death

Today 19:27 EDT

From The Rosen Law Firm PA

JXN Investors with $100,000 in Losses Have Opportunity to Join Jackson Financial Inc. Fraud Investigation with SBS Law

Tickers UNCY

Today 19:19 EDT

Faraday Future Announces This Week’s Investor Weekly Report from YT Jia Has Been Rescheduled to October 14; FFR and FFAI to Host Joint New Product Launch Event on October 14

Tickers JXN

Ear-Based Vagus Nerve Stimulation for Autonomic Regulation: Info Guide Released

Today 19:00 EDT

Via Press Release Distribution Service

Today 19:00 EDT

From Faraday Future Intelligent Electric Inc.

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages FuelCell Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FCEL

Tickers FFAI

Today 18:06 EDT

From The Rosen Law Firm PA

Sygnia Unveils Security Operations Center Hubs and Expands AI-Powered Cybersecurity Capabilities To Challenge Threat Attack Rise

Tickers FCEL

Today 18:00 EDT

From Sygnia

IMVT Investors with $100,000 in Losses Have Opportunity to Join Immunovant, Inc. Fraud Investigation with SBS Law

Today 17:43 EDT

BA Investors with $100,000 in Losses Have Opportunity to Join The Boeing Company Fraud Investigation with SBS Law

Tickers IMVT

Today 17:40 EDT

LZB Investors with $100,000 in Losses Have Opportunity to Join La-Z-Boy Incorporated Fraud Investigation with SBS Law

Tickers BA

Today 17:32 EDT

FHTX Investors with $100,000 in Losses Have Opportunity to Join Foghorn Therapeutics Inc. Fraud Investigation with SBS Law

Tickers LZB

Today 17:16 EDT

SCHL Investors with $100,000 in Losses Have Opportunity to Join Scholastic Corporation Fraud Investigation with SBS Law

Tickers FHTX

Today 17:05 EDT

Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Ultra-Rare Cholestatic Liver Diseases

Tickers SCHL

Today 17:00 EDT

From Mirum Pharmaceuticals, Inc.

First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026

Tickers MIRM

Today 16:00 EDT

From First Tracks Biotherapeutics Inc

Tickers TRAX

Mike Wood's 'One Brave Breath' Hits No. 1 Best-Seller in Multiple Amazon Categories

Today 15:59 EDT

Via Newsfile

Tickers AMZN

What Family Caregivers Need to Know

Today 15:40 EDT

Online Gaming in the Digital Age: Smart Ways to Choose Games and Play Responsibly

Today 15:38 EDT

Online Games: How Digital Entertainment Is Changing the Way People Play

Today 15:34 EDT

Online Gaming Trends: What Players Should Know Before Choosing a Gaming Platform

Today 15:32 EDT

Online Games: How to Choose Better Games and Enjoy a Safer Gaming Experience

Today 15:30 EDT

Slots Games Explained: Technology, Popular Features, and Responsible Online Entertainment

Today 15:27 EDT

New Real-World Data at ACG 2026: 90% of Adults with IBS Reported Symptom Relief After Completing SideBy Care's Virtual Multidisciplinary Program

Today 14:55 EDT

From SideBy Care

Via ACCESS Newswire

Acoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S. Electronic Health Records

Today 14:30 EDT

From BridgeBio Pharma, Inc.